Image de couverture de EFL077 - Inflammation vs. Immune-System Dysfunction in PCOS

EFL077 - Inflammation vs. Immune-System Dysfunction in PCOS

EFL077 - Inflammation vs. Immune-System Dysfunction in PCOS

Écouter gratuitement

Afficher les détails

La meilleure offre de la saison | 0,99 €/mois pendant les 3 premiers mois + 15 € de crédit Audible

6,99 €/mois par la suite. Des conditions s’appliquent. Annulation mensuelle possible.
À propos de ce titre

For our 77th episode, we discuss a study in the Journal of Clinical Endocrinology & Metabolism investigating the role of immune signaling in polycystic ovary syndrome (PCOS), now renamed polyendocrine metabolic ovarian syndrome (PMOS). Using a multiracial case-control design, the authors examined whether PCOS is characterized by chronic inflammation or whether immune dysregulation plays a more central role in its pathophysiology.

Host Chase Hendrickson, MD, MPH, MHCC, from Vanderbilt Health, is joined by regular contributor Anna Goldman, MD, from Harvard Medical School, Brigham and Women's Hospital, and Atrius Health, along with guest expert Corrine Welt, MD, Chief of Endocrinology at the University of Utah, to discuss "Multiracial Cytokine Profiling Reveals Immune Dysregulation not Chronic Inflammation in Polycystic Ovary Syndrome." Together, they explore the implications of the syndrome's recent name change, review the study's unexpected findings of lower circulating inflammatory markers in women with PCOS, and discuss the challenges of disentangling the effects of adiposity, metabolism, and immune function. The conversation highlights what these results reveal about the evolving understanding of PCOS and whether they have implications for current clinical practice.

adbl_web_anon_alc_button_suppression_t1
Aucune critique pour le moment